In another study, Karmouty-Quintana et al. showed that the A2BAR activation promotes endothelin-1 and IL-6 release from endothelial cells and pulmonary artery myocytes, thus contributing to vessel wall remodelling and PAH progression [80]. The gene discussed is IL6; the disease is pulmonary arterial hypertension.